HLA-A and neoplasm: Moreover, the presence of B cell-rich HLA-A-positive TLSs in ESCC is associated with better therapeutic response, and B cells promote antibody-mediated tumor recognition and cytokine secretion through their activation in TLSs of ESCC, thereby improving the efficacy of ICB (44).